2016
DOI: 10.1111/hiv.12372
|View full text |Cite
|
Sign up to set email alerts
|

The cost‐effectiveness of treating triple coinfection with HIV, tuberculosis and hepatitis C virus

Abstract: It is known that treating patients with HIV who are coinfected with TB or HCV implies high cost and low efficacy, but it is possible that the population with triple infections could achieve important benefits in terms of years of life gained.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 34 publications
0
0
0
Order By: Relevance